Literature DB >> 23723238

A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1.

Liron Bar-Peled1, Lynne Chantranupong, Andrew D Cherniack, Walter W Chen, Kathleen A Ottina, Brian C Grabiner, Eric D Spear, Scott L Carter, Matthew Meyerson, David M Sabatini.   

Abstract

The mTOR complex 1 (mTORC1) pathway promotes cell growth in response to many cues, including amino acids, which act through the Rag guanosine triphosphatases (GTPases) to promote mTORC1 translocation to the lysosomal surface, its site of activation. Although progress has been made in identifying positive regulators of the Rags, it is unknown if negative factors also exist. Here, we identify GATOR as a complex that interacts with the Rags and is composed of two subcomplexes we call GATOR1 and -2. Inhibition of GATOR1 subunits (DEPDC5, Nprl2, and Nprl3) makes mTORC1 signaling resistant to amino acid deprivation. In contrast, inhibition of GATOR2 subunits (Mios, WDR24, WDR59, Seh1L, and Sec13) suppresses mTORC1 signaling, and epistasis analysis shows that GATOR2 negatively regulates DEPDC5. GATOR1 has GTPase-activating protein (GAP) activity for RagA and RagB, and its components are mutated in human cancer. In cancer cells with inactivating mutations in GATOR1, mTORC1 is hyperactive and insensitive to amino acid starvation, and such cells are hypersensitive to rapamycin, an mTORC1 inhibitor. Thus, we identify a key negative regulator of the Rag GTPases and reveal that, like other mTORC1 regulators, Rag function can be deregulated in cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23723238      PMCID: PMC3728654          DOI: 10.1126/science.1232044

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  31 in total

Review 1.  Membrane-coating lattice scaffolds in the nuclear pore and vesicle coats: commonalities, differences, challenges.

Authors:  Nina C Leksa; Thomas U Schwartz
Journal:  Nucleus       Date:  2010-03-12       Impact factor: 4.197

2.  Mitochondria regulate autophagy by conserved signalling pathways.

Authors:  Martin Graef; Jodi Nunnari
Journal:  EMBO J       Date:  2011-04-05       Impact factor: 11.598

3.  PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors.

Authors:  Funda Meric-Bernstam; Argun Akcakanat; Huiqin Chen; Kim-Anh Do; Takafumi Sangai; Farrell Adkins; Ana Maria Gonzalez-Angulo; Asif Rashid; Katherine Crosby; Mei Dong; Alexandria T Phan; Robert A Wolff; Sanjay Gupta; Gordon B Mills; James Yao
Journal:  Clin Cancer Res       Date:  2012-03-15       Impact factor: 12.531

4.  Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.

Authors:  Yasemin Sancak; Liron Bar-Peled; Roberto Zoncu; Andrew L Markhard; Shigeyuki Nada; David M Sabatini
Journal:  Cell       Date:  2010-04-08       Impact factor: 41.582

5.  mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase.

Authors:  Roberto Zoncu; Liron Bar-Peled; Alejo Efeyan; Shuyu Wang; Yasemin Sancak; David M Sabatini
Journal:  Science       Date:  2011-11-04       Impact factor: 47.728

6.  A conserved coatomer-related complex containing Sec13 and Seh1 dynamically associates with the vacuole in Saccharomyces cerevisiae.

Authors:  Svetlana Dokudovskaya; Francois Waharte; Avner Schlessinger; Ursula Pieper; Damien P Devos; Ileana M Cristea; Rosemary Williams; Jean Salamero; Brian T Chait; Andrej Sali; Mark C Field; Michael P Rout; Catherine Dargemont
Journal:  Mol Cell Proteomics       Date:  2011-03-31       Impact factor: 5.911

7.  Novel G proteins, Rag C and Rag D, interact with GTP-binding proteins, Rag A and Rag B.

Authors:  T Sekiguchi; E Hirose; N Nakashima; M Ii; T Nishimoto
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

8.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

Review 9.  Target of rapamycin (TOR) in nutrient signaling and growth control.

Authors:  Robbie Loewith; Michael N Hall
Journal:  Genetics       Date:  2011-12       Impact factor: 4.562

10.  Selective regulation of autophagy by the Iml1-Npr2-Npr3 complex in the absence of nitrogen starvation.

Authors:  Xi Wu; Benjamin P Tu
Journal:  Mol Biol Cell       Date:  2011-09-07       Impact factor: 4.138

View more
  428 in total

Review 1.  mTOR in health and in sickness.

Authors:  Dritan Liko; Michael N Hall
Journal:  J Mol Med (Berl)       Date:  2015-09-22       Impact factor: 4.599

2.  Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade.

Authors:  Juan F Linares; Angeles Duran; Miguel Reina-Campos; Pedro Aza-Blanc; Alex Campos; Jorge Moscat; Maria T Diaz-Meco
Journal:  Cell Rep       Date:  2015-08-13       Impact factor: 9.423

Review 3.  Amino acid management in cancer.

Authors:  Zhi-Yang Tsun; Richard Possemato
Journal:  Semin Cell Dev Biol       Date:  2015-08-12       Impact factor: 7.727

4.  p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.

Authors:  Stuti Agarwal; Catherine M Bell; Shirley M Taylor; Richard G Moran
Journal:  Mol Cancer Res       Date:  2015-09-18       Impact factor: 5.852

5.  Prevention of premature death and seizures in a Depdc5 mouse epilepsy model through inhibition of mTORC1.

Authors:  Lindsay K Klofas; Brittany P Short; Chengwen Zhou; Robert P Carson
Journal:  Hum Mol Genet       Date:  2020-05-28       Impact factor: 6.150

6.  Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome.

Authors:  Suchithra Menon; Christian C Dibble; George Talbott; Gerta Hoxhaj; Alexander J Valvezan; Hidenori Takahashi; Lewis C Cantley; Brendan D Manning
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

7.  mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.

Authors:  Andrés Norambuena; Horst Wallrabe; Lloyd McMahon; Antonia Silva; Eric Swanson; Shahzad S Khan; Daniel Baerthlein; Erin Kodis; Salvatore Oddo; James W Mandell; George S Bloom
Journal:  Alzheimers Dement       Date:  2016-09-29       Impact factor: 21.566

8.  The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex.

Authors:  Yilun Deng; Yuejuan Qin; Subramanya Srikantan; Anqi Luo; Zi-Ming Cheng; Shahida K Flores; Kris S Vogel; Exing Wang; Patricia L M Dahia
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

9.  The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1.

Authors:  Liron Bar-Peled; Lynne Chantranupong; Zhi-Yang Tsun; Roberto Zoncu; Tim Wang; Choah Kim; Eric Spooner; David M Sabatini
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

10.  Emerging role of mTOR in the response to cancer therapeutics.

Authors:  Erika Ilagan; Brendan D Manning
Journal:  Trends Cancer       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.